Literature DB >> 29961960

An NIR-Fluorophore-Based Therapeutic Endoplasmic Reticulum Stress Inducer.

Yang Wang1, Shenglin Luo1, Chi Zhang1, Xingyun Liao1, Tao Liu1, Zhongyong Jiang1, Dengqun Liu1, Xu Tan1, Lei Long1, Yu Wang1, Zelin Chen1, Yunsheng Liu1, Fan Yang1, Yibo Gan1, Chunmeng Shi1.   

Abstract

The endoplasmic reticulum (ER) stress signaling or unfolded protein response (UPR) is a common feature of many human diseases, including cancer. Excessive activation of ER stress directly induces cell death, holding a new promising strategy for the therapeutic intervention of cancer. Current ER-stress-inducing agents mainly target UPR components or proteasomes, which exert limited treatment efficacy and undesired side effects due to unselective ER stress and poor tumor-specific distribution. In this study, a unique near-infrared (NIR) fluorophore, IR-34, is synthesized and identified to selectively and efficiently trigger tumoricidal ER stress by targeting the mitochondrial protein NDUFS1. IR-34 is demonstrated to specifically accumulate in living cancer cells for tumor NIR imaging and drastically inhibit tumor growth and recurrence without causing apparent toxicity. Thus, this multifunctional NIR fluorophore may represent a novel theranostic agent for tumor imaging-guided treatment and also strengthens the idea that mitochondria could be a useful target for therapeutic ER stress in cancer cells.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  ER stress; NDUFS1; NIR fluorphores; mitochondrial complexes I

Year:  2018        PMID: 29961960     DOI: 10.1002/adma.201800475

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  9 in total

1.  Tumor-Associated Immune-Cell-Mediated Tumor-Targeting Mechanism with NIR-II Fluorescence Imaging.

Authors:  Homan Kang; Md Shamim; Xiaoran Yin; Eeswar Adluru; Takeshi Fukuda; Shinya Yokomizo; Hyejin Chang; Seung Hun Park; Yanan Cui; Austin J Moy; Satoshi Kashiwagi; Maged Henary; Hak Soo Choi
Journal:  Adv Mater       Date:  2022-01-18       Impact factor: 30.849

2.  Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade.

Authors:  Qiuyi Li; Cheng Chen; Jinxia Kong; Lian Li; Junlin Li; Yuan Huang
Journal:  Acta Pharm Sin B       Date:  2021-12-29       Impact factor: 14.903

Review 3.  Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.

Authors:  Xianglei Fu; Yanbin Shi; Tongtong Qi; Shengnan Qiu; Yi Huang; Xiaogang Zhao; Qifeng Sun; Guimei Lin
Journal:  Signal Transduct Target Ther       Date:  2020-11-06

4.  Tandem Molecular Self-Assembly Selectively Inhibits Lung Cancer Cells by Inducing Endoplasmic Reticulum Stress.

Authors:  Debin Zheng; Yumiao Chen; Sifan Ai; Renshu Zhang; Zhengfeng Gao; Chunhui Liang; Li Cao; Yaoxia Chen; Zhangyong Hong; Yang Shi; Ling Wang; Xingyi Li; Zhimou Yang
Journal:  Research (Wash D C)       Date:  2019-12-03

5.  Engeletin ameliorates pulmonary fibrosis through endoplasmic reticulum stress depending on lnc949-mediated TGF-β1-Smad2/3 and JNK signalling pathways.

Authors:  Jinjin Zhang; Xiaoqing Chen; Hongbin Chen; Rongrong Li; Pan Xu; Changjun Lv; Bo Liu; Xiaodong Song
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

6.  Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemia-targeted imaging and therapy.

Authors:  Chi Zhang; Tao Liu; Peng Luo; Li Gao; Xingyun Liao; Le Ma; Zhongyong Jiang; Dengqun Liu; Zeyu Yang; Qingzhi Jiang; Yu Wang; Xu Tan; Shenglin Luo; Yang Wang; Chunmeng Shi
Journal:  Sci Adv       Date:  2021-01-01       Impact factor: 14.136

7.  Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy.

Authors:  Shuangquan Gou; Nanxi Chen; Xiaoai Wu; Menghang Zu; Shixiong Yi; Binwu Ying; Fangyin Dai; Bowen Ke; Bo Xiao
Journal:  Acta Pharm Sin B       Date:  2021-07-08       Impact factor: 11.413

8.  Combating multidrug resistance and metastasis of breast cancer by endoplasmic reticulum stress and cell-nucleus penetration enhanced immunochemotherapy.

Authors:  Weixi Jiang; Li Chen; Xun Guo; Chen Cheng; Yuanli Luo; Jingxue Wang; Junrui Wang; Yang Liu; Yang Cao; Pan Li; Zhigang Wang; Haitao Ran; Zhiyi Zhou; Jianli Ren
Journal:  Theranostics       Date:  2022-03-21       Impact factor: 11.600

9.  ZWZ-3, a Fluorescent Probe Targeting Mitochondria for Melanoma Imaging and Therapy.

Authors:  Zengjin Liu; Hailan Wang; Changzhen Sun; Yuanmin He; Tong Xia; Jianv Wang; Xia Xiong; Qingbi Zhang; Sijin Yang; Li Liu
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.